Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKTS2M)

Drug Name

Rifaximin DR Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting DNA-directed RNA polymerase (RNAP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Rifabutin	DM1YBHK	Mycobacterium infection	1B10-1B21	Approved	[2]
Rifapentine	DMCHV4I	Pulmonary tuberculosis	1B10.Z	Approved	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
DNA-directed RNA polymerase (RNAP)	TTHKJLN	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3	Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7.